IDEAYA Biosciences, Inc. IDYA Stock Issuance Proceeds
Stock Issuance Proceeds at other companies
Other financials
Where this comes from
Reported directly by IDEAYA Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: IDEAYA Biosciences, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about IDEAYA Biosciences, Inc.'s stock issuance proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is IDEAYA Biosciences, Inc.'s stock issuance proceeds?
- IDEAYA Biosciences, Inc. (IDYA) reported stock issuance proceeds of $1.19M in Q1 2026.
- How has IDEAYA Biosciences, Inc.'s stock issuance proceeds changed year-over-year?
- IDEAYA Biosciences, Inc.'s stock issuance proceeds increased by 4.9% year-over-year, from $1.13M to $1.19M.
- What is the long-term trend for IDEAYA Biosciences, Inc.'s stock issuance proceeds?
- Over 4 years (2021 to 2025), IDEAYA Biosciences, Inc.'s stock issuance proceeds has grown at a -100.0% compound annual growth rate (CAGR), from $85.99M to $0.
- What does stock issuance proceeds mean?
- Cash received from issuing common stock — IPOs, secondary offerings, DRIP, employee stock purchase plans, and option exercises.